Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas

This study has been completed.
Information provided by:
Celgene Corporation Identifier:
First received: December 17, 2003
Last updated: January 2, 2007
Last verified: January 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: June 2005
  Estimated Primary Completion Date: No date given